Information  X 
Enter a valid email address

System1 Group PLC (SYS1)


Tuesday 04 January, 2022

System1 Group PLC

Directorate Change

RNS Number : 3915X
System1 Group PLC
04 January 2022




4 January 2022


System1 Group PLC (AIM: SYS1)

("System1", or "the Company", or "the Group") 

Directorate Change

System1 Group plc (AIM: SYS1) today announces that, as planned, Stefan Barden will step down as CEO and from the board of directors on 31 January and revert to his previous role as an adviser to the board of directors on strategy and technology. System1's founder, John Kearon, will return to the CEO role.

John Kearon said: " I would like to express the whole Company's gratitude to Stefan for his immeasurable executive contribution over the past 18 months. Including playing a leading role implementing the new strategy centred around our Marketing Predictions platform, rebuilding our 'back-office' from first principles to support it, and reinforcing our Executive Team with key hires to add to our own home-grown talent, including the appointment of a chief operating officer. I'm very pleased Stefan will continue with us in his original advisory role. Thank you, Stefan".

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement, this inside information is now considered to be in the public domain and the Company confirms  that it currently has no inside information.


The Company can be found at




For further information, please contact:

System1 Group PLC  Tel: +44 (0)20 7043 1000 John Kearon, Founder and Chief Executive Officer

Chris Willford, Chief Financial Officer



Canaccord Genuity Limited  Tel: +44 (0)20 7523 8000 

Simon Bridges / Andrew Potts



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t